SIONSionna Therapeutics Inc. Common Stock
5.290USD-15.36%Mkt Cap: 239.17M $P/E: —3d ago
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-dire…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap239.17M $
Enterprise Value46.61M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-75.27M $
Revenue/Share—
Last Price5.290 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees59
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.18
PEG—
EV/EBITDA-0.43
EV/Revenue—
P/S—
P/B0.94
EPS (TTM)-1.90
EPS (Forward)-2.53
52W Range
4.0103% of range54.97
52W High54.97 USD
52W Low4.010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-24.53%
ROA-23.09%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-66.30M $
CapEx (TTM)377.00K $
FCF Margin—
FCF Yield-19.00%
Net Debt-202.96M $
Net Debt/EBITDA1.86
Balance Sheet
Debt/Equity0.03
Current Ratio20.05
Quick Ratio19.57
Book Value/Sh5.885 USD
Cash/Share4.668 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.17 USD
Upside (mean)+186.7%
Target Range5.000 USD – 63.00 USD
$5.000+186.7% to mean$63.00
# Analysts6
Ownership
Shares Out.45.21M
Float17.03M
Insiders6.84%
Institutions107.16%
Short Interest
Short Ratio7.5d
Short % Float15.06%
Short % Out.9.29%
Shares Short4.20M
Short (prev mo.)5.52M
Technical
SMA 5036.68 (-85.6%)
SMA 20038.78 (-86.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)3.00M
Avg Vol (10d)8.08M
Technical Indicators
RSI (14)21.6
MACD-10.7230
MACD Signal-8.3927
MACD Hist.-2.3303
BB Upper69.98 USD
BB Middle26.78 USD
BB Lower-16.4229 USD
BB Width322.65%
ATR (14)3.753 USD
Vol Ratio (20d)0.45x